Dr. Scott Doughman Developed Pure One for All People

DR SCOTT DOUGHMAN is Founder and President of Source-Omega, LLC. He is the recipient of several prestigious awards, including a Fellowship in Nutritional Biochemistry from the National Institutes of Health (NIH) for studying the Role of Omega-3s and EFAs in Metabolic Diseases.  Dr Doughman, PhD has gone on to author several scientific research studies and two clincial review articles on source algae oil Omega-3s for OMEGA-3 DHA THERAPY™ (Curr. Diabetes Rev, 2007; Submitted For Publication, 2010).  Dr Doughman's Integrative Omega-3 Therapies have helped launch the company Source-Omega offering the first optimized algae oil product called Pure One™ the Next Generation Plant Based Omega-3™ used for all optimized dosing programs to build up the omega-3 levels in the body.  His vast knowledge of the topic and amazing customer results drive his 'essential-to-you' research and writings, articles and blogs. 

In addition to his expert insight into the mechanisms of disease, Dr Scott Doughman's leadership helped create the entrepreneurial start-up named Source-Omega™ because microalgae oil is THE SOURCE where fish oil omega-3s come from.

Scott went to the source. He came back with Pure One™.  "The proof is in the quality and results" says Scott. "We build results, our business is growing out of that essential service.”

Dr Doughman’s insight into Omega-3 metabolism has attracted attention in the scientific community, yet Scott’s mission is applying his knowledge as an educator in lipidology for applied therapy and results, risk free. 

Dr Doughman understands the global need for omega-3 DHA.  His international collaborations have developed from his mission as a scientist and speaker on topics Serving Diabetes.  His annual volunteerism as a Visiting Faculty Member in Molecular Biology in South India is where Scott enjoys collaborating with MDs, PhDs and students.  Through annual visits, Scott has built a network of interested scientists and doctors seeking to learn more about vegetarian Omega-3s in gene regulation, disease prevention and medicine.

In 2006 Dr Doughman developed the global idea called Pure One™. Scott first became involved with Omega-3s at the University of Wisconsin while earning his Ph.D. in Cell and Molecular Biology in the Department of Biochemistry (the historic birthplace of Vitamin D research).  His doctoral work on Lipid Dependent Neurotransmitter Release Mechanisms in the Brain led to work in Developmental Biology and then on to Nutritional Biochemistry and Omega-3 Metabolism during post-graduate work in the Department of Nutrition at the University of North Carolina - Chapel Hill, in the School of Public Health, associated with the Department of Epidemiology. 

Scott’s public health exposure coupled with his scientific curiosity led him to uniquely understand how Omega-3 DHA is needed to properly care for Lipid Metabolic Diseases.  This led to interests in standardizing the Omega-3 DHATherapy™ as a global necessity and opportunity, for which Source-Omega™ and Dr Doughman claim their Patent Pending status.

Dr. Doughman’s efforts are backed by 5 therapy programs recommending correct amounts of Omega-3 DHA daily.* 

"High blood fat levels are common in adults with weight gain and with low dietary DHA omega-3 levels.  High blood fat levels called high triglycerides are a risk factor screened for during the cholesterol test.  High blood fat levels may lead to lipotoxicity, insulin resistance, and metabolic diseases." * 

EMAIL: scott@source-omega.com

CALL ME: 919-360-5275 (9am-5pm EST)